Prof. John B. Kaneene (left) from Michigan State University, Ms. Brenda Nakazibwe (middle) and Mr. Charles Francis Kibalama (right) from Ministry of Science, Technology and Innovation (MoSTI) in an evaluation meeting with CEBIGH leadership held on Tuesday, 10th May, 2022 in the Centre conference room.
CoVAB’s science, research, and innovations shared facility, the Centre for Biosecurity and Global Health (CEBIGH) hosted a team from Ministry of Science, Technology and Innovation together with a distinguished Professor, John B. Kaneene from Michigan State University on 10th May 2022 for an evaluation activity of its PRESIDE Projects.
During a meeting which was held in the facility’s conference room, the Principal Investigator of the Centre, Prof. John David Kabasa appreciated the government of Uganda for supporting the College research and innovation programs. He also appreciated Prof. Kaneene for his mentorship in ensuring that CEBIGH is an internationally standardized reference laboratory.
“We acknowledge the President of the Republic of Uganda, H.E. Yoweri Kaguta Museveni and the Government of Uganda for their support towards research, science, technology and innovation. CEBIGH is a platform for all researchers/scientists to discover solutions to the world’s problems and develop innovations,” said Prof. Kabasa. Adding that, during the structural developments of the facility, Prof. Kaneene was a key adviser on ensuring that the CEBIGH fulfills the requirements for an internationally recognized laboratory.
The Director of CEBIGH Prof. Enock Matovu highlighted on the Centre’s progress and projects it is currently focusing on.
The Centre for Biosecurity and Global Health (CEBIGH) leadership together with evaluators from Ministry of Science, Technology and Innovation and Michigan State University in a meeting on CEBIGH being a major actor in the Pathogen Economy which was held on 10th May, 2022 in the Centre Conference room.
“CEBIGH is critical on developing drugs and vaccines as a solution to minimize and end existing and emerging diseases that distress humans, animals, plant life and the entire ecosystem,” reported Prof. Matovu.
He further gave a highlight on the different PRESIDE research projects housed in CEBIGH which included;
The COVID-19 Biomarker Project by Dr. Kato Charles Drago (Principal Investigator), which is running research on the different classes of COVID- 19 infections to reduce on the burden of patient crowds in hospitals. This research project seeks for markers that are used in classification of COVID- 19 infections and groups the patients into; the controls, symptomatic, asymptomatic and severe based on their markers. The project is as well developing diagnostic kits that will be used for early prediction of who is likely to become severe in infection.
COVID-19 Sub- Unit Vaccine Project by Prof. Matovu Enock (Principal Investigator), which is producing a COVID-19 Vaccine.
Saliva Diagnostic Kit by Prof. Charles Ibingira (Principal Investigator), which is developing time saving cost friendly COVID-19 test kits.
The Director, CEBIGH, Prof. Enock Matovu making his remarks on the progress of the PRESIDE Projects housed in the Centre as major actors in the Pathogen economy during the evaluation meeting held in the Centre conference room on 10th May 2022.
Central Laboratory Animal Research Facility (CLARF) by Prof. John David Kabasa (Principal Investigator) and Dr. Edward Wampande (Co-Principal Investigator), which is a reference laboratory with a breeding unit for lab animals and a trial unit to test the efficacy of developed vaccines and drugs.
This activity was followed by a guided tour led by Prof. Matovu to the Center’s Biosafety Levels 2 and 3, and the Central Laboratory Animal Research Facility which is still under construction.
After the visit to the facilities in the Centre, Prof. Kaneene applauded the work well done by the Centre leadership. He however advised that there’s need to consider recruitment of highly specialized personnel in the reference animal facility which is in completion stages of construction.
Presidential Scientific Initiative on Epidemics (PRESIDE), is responsible for the fast-tracking of research and innovations of Vaccines, Drugs and Therapeutics as response to emerging diseases and other public health threats.
CEBIGH is one of those units directed by H.E. the President of the Republic of Uganda to be established at Makerere University in realization of a regional Veterinary College, College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB). It is one of the research and development service entities that are repositioning CoVAB to become a major driver of science, strategic research and service nationally, regionally and globally, hence a major actor in the pathogen economy.
On Friday, March 28th, 2025, alumni of molecular biology gathered at Mestil Hotel in Kampala to honor Prof. George William Lubega, a distinguished teacher whose dedication to nurturing scientists has left an indelible mark on Uganda’s scientific community.
The event, organized by the alumni, celebrated Prof. Lubega’s pivotal role in transforming students into leaders in molecular biology. Dr. Claire Mack Mugasa, Dean of the School of Biosecurity, Biotechnical, and Laboratory Sciences at Makerere University, shared heartfelt recollections of Prof. Lubega’s impact, including his scholarship support and passionate teaching style. Dr. Mugasa noted, “The scientists we have in Uganda are a testimony to his boldness. He has been a father to us in science, and now we are fathers of others.”
Prof. Lubega expressed gratitude for the honor and acknowledged the mentorship he received from his teachers. He also highlighted his groundbreaking contributions, including patented vaccines against trypanosomiasis, and thanked Makerere University for providing an enabling environment for scientific advancement.
The event emphasized the importance of continuing his legacy through initiatives like an association of molecular biologists. The alumni expressed their deep appreciation for Prof. Lubega’s selfless efforts, which have transformed the landscape of science education in Uganda.
This celebration stands as a testament to Prof. Lubega’s lasting influence on his students, colleagues, and the scientific community at large.
Makerere University convened a symposium to explore bacteriophage applications in combating antimicrobial resistance (AMR) and addressing health, agricultural, and environmental challenges. Organized by The Alliance for Phage Research and Development Uganda Ltd (PhageTeam Uganda), the event brought together researchers from Makerere University, Kyambogo University, Kampala International University, and Ian Clarke International University, and other players, highlighting a collaborative approach to tackling global and local issues.
Day two of the symposium saw researchers and policy makers together with partners from the UK and USA hold a discourse on the best way forward in the promotion of bacteriophage research and production in the country to support efforts against anti-microbial resistance.
Dr. Jesca Nakavuma, the lead phage researcher from the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), gave the background to the workshop.
Speaking at the event held at Hilton Garden Inn, Dr. Jesca Nakavuma, the lead phage researcher from the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, stressed the urgent need for alternative antimicrobial agents due to the rise in drug resistance and limited discovery of new antibiotics. Bacteriophages, natural viruses that target bacteria, she said, were identified as a promising solution to revolutionize disease control, treatment, and food security. She said research in this area was key because humankind was at risk of the impending calamity of life-threatening treatment failure.
Prof. Robert Wamala, represented the VC, Prof. Barnabas Nawangwe.
Prof. Robert Wamala, Makerere University‘s Director for Research, Innovations, and Partnerships, who spoke on behalf of the Vice Chancellor, Prof. Barnabas Nawangwe, underscored the importance of building local capacity in phage research. He noted that such efforts could enhance Uganda’s resilience against AMR and yield homegrown solutions for human, animal, and crop health.
As the world grapples with the growing threat of antimicrobial resistance (AMR), bacteriophage research offers a promising alternative. Phages, which are natural enemies of bacteria, have the potential to revolutionize the approach to treatment, disease control, and food security, he noted. He said building local expertise in phage application can enhance Uganda’s resilience against AMR and produce sustainable homegrown solutions to health and environmental challenges.
A section of the stakeholders who participated in the discourse listened attentively.
Prof. Robert Wamala said Makerere University was committed to supporting cutting-edge research and innovation that addresses national and global challenges in line with the university’s role in knowledge generation, technology advancement, and policy influence. The importance of regulatory institutions, he said, cannot be overemphasized in this endeavor, since they enforce compliance, uphold ethical standards, and foster an enabling environment for impactful research and innovation. He said the engagement presented an opportunity to strengthen collaboration between researchers, institutions, and regulatory bodies to ensure that the outcomes are scientifically sound and are aligned to the national development priorities and global best practices.
Dr. Claire M. Mugasa, the Dean of the School of Biosecurity, Biotechnical and Laboratory Sciences (SBLS), CoVAB reiterated the fact that antimicrobial resistance was on the rise in Uganda and Africa, more than elsewhere in the world. She said it was time now that efforts be intensified in looking for sustainable options to curb the dangerous trends. She said this cuts across the human and the animals. She said it was an opportune time for players to come together to find ways of getting the required alternative. She said by coming together, the different ideas developed individually would in a concerted effort, pulling resources together for a way forward.
Dr. Claire M. Mugasa, the Dean of the School of Biosecurity, Biotechnical and Laboratory Sciences (SBLS) addressed the meeting.
During the discourse, several subjects were addressed, including an introduction to antimicrobial resistance, phage biology, phage application, and lessons learnt from the establishment of a phage research centre in the UK, which was presented by Prof. Martha Clokie from the University of Leicester. This initiative reflects a commitment to fostering innovation, collaboration, and regulatory compliance, positioning Uganda as a leader in sustainable solutions for global challenges.
The symposium was sponsored by Global AMR Innovation Fund (GAMRIF), through a grant to the UK Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with Phages for Global Health.
Bacteriophage research and its applications were the focal point of the 1st Symposium on Bacteriophage Research and Applications, convened by Makerere University‘s College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) on Thursday, March 27, 2025. This landmark event showcased Uganda’s strides in harnessing bacteriophages as innovative solutions to antimicrobial resistance (AMR) and other pressing health and agricultural challenges.
Tobi Elaine Nagel, the President of Phages for Global Health (USA), was one of the presenters.
Key speakers included Dr. Jesca Nakavuma, CoVAB (Makerere University), who showcased Uganda’s pioneering phage research initiatives and vision. Tobi Elaine Nagel, the President of Phages for Global Health (USA), discussed the global significance of phage research. Prof. Martha Clokie, from the University of Leicester’s Centre for Phage Research (UK), shared insights into the latest advancements in phage therapy. Dr. Robert Blasdel, representing VASALE (Belgium), presented innovative solutions using bacteriophages. Ms. Abigail Riggs, from the Foreign, Commonwealth and Development Office (UK), emphasized international partnerships and policy development.
Prof. Robert Wamala, Director, Directorate of Research, Innovation and Partnerships addressed the participants.
Speaking at the event, Prof. Edward Wamala, Makerere University’s Director of Research, Innovation and Partnerships, who represented the Vice Chancellor Prof. Barnabas Nawangwe at the event, highlighted the critical role of bacteriophage research in addressing the global threat of antimicrobial resistance (AMR). He explained how the misuse and overuse of antibiotics in human health, agriculture, and aquaculture have accelerated the emergence of drug-resistant bacterial strains, rendering standard treatments ineffective. Citing statistics from the World Health Organization, he pointed out that AMR claims over 1.3 million lives annually, a number expected to rise without urgent action. He lamented the stagnation of new antibiotic development due to high research costs and rapid bacterial resistance, making bacteriophage therapy a powerful and promising alternative.
A Section of the stakeholders that participated in the engagement.
Prof. Wamala expressed Makerere University’s commitment to advancing research that addresses critical societal challenges, aligning with its mission of generating transformative knowledge and fostering sustainable development. He emphasized Uganda’s potential to lead in bacteriophage research, driven by multi-disciplinary partnerships and capacity building. He also highlighted ongoing studies into aquaculture-specific bacteriophages at CoVAB as an example of how phage technology can revolutionize sectors like agriculture while addressing AMR. Through such efforts, the university aims to position Uganda as a global leader in innovative solutions to combat antimicrobial resistance and enhance public health.
Dr. Jesca Nakavuma, from the College of Veterinary Medicine, Animal Resources, and Biosecurity.
Dr. Jesca Nakavuma, widely regarded as the mother of phages in Uganda, delivered a compelling presentation at the Symposium, where she detailed the impressive progress of phage research in Uganda since its inception in 2017. She highlighted Makerere University’s pioneering efforts, starting with a cohort of five undergraduate students, which have since expanded into groundbreaking research addressing challenges in agriculture, clinical health, food safety, and environmental safety. Key achievements include advancements in E. coli and Salmonella detection, tackling avian colibacillosis, and innovations in decontamination methods, underscoring the transformative potential of phage technology in combating antimicrobial resistance and enhancing public health.
The University leadership included Prof. Robert Wamala (R) and Assoc. Prof. James Acai Okwee (C), Deputy Principal CoVAB.
The symposium honored collaborative efforts, including the establishment and accomplishments of Phage Team Uganda, which developed a repository of 125 characterized phage isolates and trained over 20 PhDs, MScs, and BSc students. Partnerships with international organizations such as IDRC InnoVet AMR and AU Safe Fish have significantly contributed to advancements in antimicrobial resistance and aquaculture.
The participants were actively involved in the discussions.
Despite these achievements, Dr. Nakavuma noted challenges such as insufficient facilities for large-scale phage production, regulatory limitations, and financial constraints. She affirmed that despite the challenges, the team remained ambitious, envisioning the creation of a fully equipped Phage Research and Development Center, the commercialization of phage products, and the establishment of policy frameworks to support the use of phages in Uganda.
The Deputy Principal of CoVAB, Prof. James Acai Okwee, warmly welcomed the partners to the conference and acknowledged their invaluable contributions to the college’s research efforts. He emphasized the importance of collaboration in driving innovation and achieving impactful results, highlighting the pivotal role that partnerships play in fostering academic and scientific growth. Prof. Okwee’s remarks set an encouraging tone for the conference, reinforcing the college’s commitment to advancing research initiatives and creating opportunities for shared learning and development.
Part of the audience at the symposium.
The event that attracted the participation of various stakeholders including academia, civil society, and policy makers, concluded with acknowledgments of the efforts of Phage Team Uganda, collaborators, and funders, setting the stage for an exciting future in Uganda’s journey to combat antimicrobial resistance and ensure food and environmental safety.